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ABSTRACT
Insulin receptor substrates (Irs1, 2, 3 and Irs4) mediate the actions of insulin/IGF1 signaling. They have similar structure, but distinctly regulate
development, growth, and metabolic homeostasis. Irs2 contributes to central metabolic sensing, partially by acting in leptin receptor (LepRb)-
expressing neurons. Although Irs4 is largely restricted to the hypothalamus, its contribution to metabolic regulation is unclear because Irs4-null mice
barely distinguishable from controls. We postulated that Irs2 and Irs4 synergize and complement each other in the brain. To examine this possibility,
we investigated the metabolism of whole body Irs4
 /y mice that lacked Irs2 in the CNS (bIrs2
 /   Irs4
 /y) or only in LepRb-neurons
(Lepr
ΔIrs2 Irs4
 /y). bIrs2
 /   Irs4
 /y mice developed severe obesity and decreased energy expenditure, along with hyperglycemia and insulin
resistance. Unexpectedly, the body weight and fed blood glucose levels of Lepr
ΔIrs2 Irs4
 /y mice were not different from Lepr
ΔIrs2 mice, suggesting
that the functions of Irs2 and Irs4 converge upon neurons that are distinct from those expressing LepRb.
& 2013 The Authors. Published by Elsevier GmbH. All rights reserved.
Keywords Insulin receptor substrate 2; Insulin receptor substrate 4; Leptin; Obesity; Nutrient homeostasis; Energy balance
1. INTRODUCTION
The hypothalamus integrates signals from peripheral tissues and central
nodes to regulate feeding, energy balance, nutrient ﬂux, and counter-
regulatory responses that maintain nutrient homeostasis [1]. Insulin is
secreted from the pancreatic beta-cells during meals to promote
peripheral nutrient homeostasis [2]; however, it also modulates energy
and glucose homeostasis by acting on hypothalamic and dopaminergic
neurons [3]. By comparison, leptin produced by adipocytes is a
dominant signal that informs the brain about peripheral energy stores
[4]. Leptin binds to the long form of the leptin receptor (LepRb) found
largely—but not entirely—on hypothalamic neurons [5]. LepRb neurons
sense and integrate signals relevant to nutrient homeostasis to control
satiety, energy balance and metabolism [4]. LepRb generates multiple
downstream signals by activating JAK2 and recruiting SHP2, STAT3 and
STAT5, along with SH2B, Irs1/2 and Irs4 [6,7].
The insulin receptor substrates (Irs1, 2, 3 and 4) are principle targets for
the insulin and IGF1 receptor tyrosine kinases, which play a central role
in somatic growth and metabolic regulation [8]. IRS-proteins are also
phosphorylated by the receptors for some cytokines (IL4, IL9, IL13),
growth hormone and leptin in various cells and tissues [7,9–14]. The
IRS-proteins share a common structure, including an NH2-terminal
pleckstrin homology (PH) domain followed by a phosphotyrosine binding
(PTB) domain, and a tail containing many Tyr and Ser/Thr phosphoryla-
tion sites. The PH and PTB domains mediate recruitment to appropriate
activated receptors in the plasma membrane [15,16]. Although the
COOH-terminal amino acid sequences of the various IRS-proteins
diverge signiﬁcantly, multiple short tyrosine phosphorylation motifs
can bind and activate similar SH2-domain containing proteins, including
the type 1 phosphatidylinositol 3-kinase [17].
The various IRS-proteins have distinct physiologic functions. These
differences in biological speciﬁcity among the various Irs-proteins may
be conferred by sequence divergence or by differences in patterns of
expression. Irs1 and Irs2 are widely expressed in mammalian tissues,
whereas Irs3 is largely restricted to nonhuman adipose tissue (where it
promotes adipogenesis [18,19]). Although some reports describe a role
http://dx.doi.org/10.1016/j.molmet.2013.10.004
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is expressed mainly in the hypothalamus in healthy animals [23–25].
Potential overlap in the expression of Irs1 and Irs2 with Irs4 appears to
occur mainly in neurons of the ventral hypothalamus [24]. Based upon
genetic deletion experiments, Irs1 promotes embryonic and postnatal
body growth, and mediates insulin sensitivity in classical insulin target
tissues [26]. By comparison, Irs2 mediates several important functions
that are not shared with Irs1—including pancreatic beta-cell growth and
survival, CNS/hypothalamic nutrient sensing, endothelial cell function,
and sensitivity to neurodegenerative disease [27–29]. Irs1
 /  mice
develop insulin resistance that is compensated by elevated circulating
insulin and β-cell/islet growth, whereas Irs2
 /  mice develop diabetes
owing to the combined effects of insulin resistance and the progressive
loss of pancreatic β-cells [30]. Together Irs1 and Irs2 apparently
mediate some essential functions, since mice null for both genes die
before weaning [8].
The deletion of Irs2 speciﬁcally in the CNS can extend life span while
producing early-onset obesity, insulin resistance and glucose intolerance
[31,32]. The metabolic phenotypes resulting from Irs2 ablation are at
least in part attributable to Irs2 function in a relatively small subset of
LepRb-expressing neurons in the brain [29]. In contrast, while Irs4 is
highly conserved and displays a very speciﬁc and restricted pattern of
expression that overlaps with LepRb cells in the ventral hypothalamus,
the deletion of Irs4 alone has very mild or no effects upon energy
balance or glucose metabolism in mice [33]. To reveal a potential
physiological function for Irs4 in the CNS, we intercrossed mice without
Irs2 in the brain (bIrs2
 / –mice) with whole-body Irs4
 /y mice to
generate compound male bIrs2
 /   Irs4
 /y mice. We examined energy
balance and metabolism in these mice, and also investigated whether
there is a functional role for Irs4 in LepRb neurons.
2. MATERIAL AND METHODS
2.1. Animals
Generation of Irs4-deﬁcient mice. The Irs4 gene was obtained by
screening a genomic DNA library derived from mouse 129/Sv embryonic
stem (ES) cells. A DNA fragment was ligated to the pPNT vector 5′ to the
neo cassette. The neo gene was ﬂanked by EcoRv-Avr II fragment and
Clal-Spel fragment derived from the Irs-4 regions 5′ and 3′ to the
deleted coding region. The Irs4 targeting vector was introduced into R1
ES cells by electroporation. The transfectants were selected with
neomycin (G418) and ganciclovir. Irs4
þ/  heterozygous ES cells were
injected into C57BL/6 blastocysts. The chimeric male mice were bred
with female wild-type C57BL/6 mice. Because the Irs-4 gene is on the X
chromosome, this breeding yielded female mice heterozygous for Irs-4
disruption and male wild-type mice. The detailed breeding strategy is
described in Section 3. Lepr
ΔIrs2, bIrs2
 /  and Irs2
L/L were described
previously [29,31]. Mice were bred in our colony at Boston Childrens
Hospital or at the Harvard School of Public Health. All animals were
handled in accordance with all procedures approved by the appropriate
Institutional Animal Care and Use Committee (IACUC). Animals were fed
breeder chow diet containing 9 kcal %fat (Research diets, Inc).
2.2. Metabolic analysis
Lean and fat body mass were assessed by Dual-Energy X-ray
Absorptiometry (DEXA, GE Lunar Corp.) as previously described [34].
Blood glucose levels were measured on random-fed or overnight-fasted
animals in mouse-tail blood using Glucometer Elite (Bayer). Intraper-
itoneal glucose tolerance test was performed on mice fasted for 16 h
overnight. Animals were then injected intraperitoneally with D-glucose
(2 g/kg) and blood glucose levels were measured [35]. For insulin
tolerance tests, mice were fasted for a 4-h period in the light cycle
before ip injections of insulin (Humulin R, 0.8 U/kg) diluted in sterile
saline. Blood glucose concentrations were measured at indicated time
points. Blood insulin and leptin levels were determined on serum from
tail vein bleeds using a Rat Insulin ELISA kit and Mouse Leptin ELISA kit
(Crystal Chem. Inc.). For food intake measurements mice were housed
individually and food intake was measured for 2 consecutive days.
2.3. Histology and morphometric analysis
Histological analysis was performed on various tissues isolated from the
animals as previously described [36]. Morphometric analysis of gonadal
white adipose tissue from 400 cells from 4 different animals per
genotype was performed with NIH ImageJ software (http://rsb.info.nih.
gov/ij/). The determination of islet area was done by measuring and
counting islets from non-overlapping pictures that covered the entire
pancreas section area. Measurements were corrected to the total area
of the pancreas section in square microns, which was calculated using
SPOT software.
2.4. Energy expenditure
As previously described [37], physical activity and energy expenditure
were performed over a 72 h period with a Comprehensive Laboratory
Animal Monitoring System (CLAMS, Oxymax Windows 3.0.3; Columbus
Instruments, OH, USA). Mice were housed individually at room
temperature (22 1C) under an alternating 12 h light/12 h dark cycle.
Heat production was measured and analyzed by generalized linear
regression to determine the energy expenditure.
2.5. RNA extraction and qPCR
Total RNA was extracted from brown adipose tissue or from hypotha-
lamus using Trizol (Gibco BRL) and 1 mg samples were converted to
cDNA using the iscript cDNA kit (Bio-Rad Laboratories Inc.). Sample
cDNAs were analyzed in triplicate via quantitative RT-PCR for Pomc and
Agrp in hypothalamus with customized primers as previously described
[37]. Actin gene expression was used to normalize RNA content and the
relative gene product amounts were reported as mean7SEM of several
animals.
2.6. Statistical analysis
Unless otherwise stated mean values7SEM were used to make
comparisons between 2 groups; signiﬁcance was determined by a
Student's t-test. A p-value less than 0.05 was considered statistically
signiﬁcant. Generalized linear regression (SPSS, v 19) was used to
identify signiﬁcant differences in body weight and energy expenditure.
3. RESULTS
3.1. Generation of bIrs2
 /   Irs4
 /y-mice
The Irs4 targeting vector was generated by standard methods and
used for homologous recombination in 129/Sv embryonic stem cells
(Figure S1). The Novartis Gene Atlas and Allen Brain Atlas conﬁrm that
Irs4 expression is largely restricted to the ventral hypothalamus, so the
conventional whole body Irs4 knock-out is in practice restricted to the
CNS (Figure S2) [38]. Because the Irs4 gene is on the X chromosome,
there are no heterozygous knockout males. Heterozygous females and
wild-type males were bred to obtain Irs4
 /y males and Irs4
þ/  females
as well as wild-type males and females. The Irs4
 /y males and
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Figure 2: Representative H&E staining of (A) white adipose tissue (WAT) and (C) liver sections of 6-month-old bIrs2
 /   Irs4
 /y-mice, Irs4
 /y-mice, bIrs2
 /  or Irs2
L/L mice. Liver sections of
9-month-old ob/ob mice are also shown. (B) Morphometric analysis of adipocyte cell size in epididymal adipose tissue (n¼5 animals per genotype; *po0.05 vs. control).
Age (weeks)
6 81 0 1 2 14
2 months 2 months
Figure 1: bIrs2
 /   Irs4
 /y-mice are obese. (A) Average body weights of male bIrs2
 /   Irs4
 /y-mice (open squares), Irs4
 /y-mice (closed squares), bIrs2
 /  mice (open circles) and
control Irs2
L/L mice (closed circles) on regular chow diet was determined in each age group and compared by generalized linear regression (SPSS, v19). The number of mice in each group is
indicated in parentheses (mean7SD; *, Bonferroni po0.001). (B) Representative image of 3-months-old male mice. (C) Body length and (D) percent body fat was determined by DEXA using
12-week-old mice (mean7SEM; n¼8–10/genotype, *po0.05 vs. controls).
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heterozygous and Irs4
 /  mice, as well as male wild-type and Irs4
 /y
mice. To focus our study on the interaction between Irs2 and Irs4
in the CNS, we utilized previously published nestin-cre transgenic
mice intercrossed to loxP-ﬂanked alleles to delete Irs2
L/L speci-
ﬁcally in neurons (bIrs2
 / ) [31]. Mice with a combined deﬁ-
ciency of Irs2 and Irs4 were generated by intercrossing female
bIrs2
þ/   Irs4
þ/  mice with male bIrs2
 /þ  Irs4
 /y mice to
produce male bIrs2
 /   Irs4
 /y and female bIrs2
 /   Irs4
 /y
m i c e ,a sw e l la sc o n t r o lg e n o t y pes. There was no detectable
embryonic lethality or early death associated with the Irs4 null
phenotype, and the male Irs4
 /y and female Irs4
 /  mice were
fertile and displayed normal size and a healthy appearance.
3.2. Growth and energy balance in bIrs2
 /   Irs4
 /y mice
The body weight of male control (Irs2
L/L), Irs4
 /y, bIrs2
 / ,o r
bIrs2
 /   Irs4
 /y mice were monitored between 6 and 13 weeks of
age to determine whether Irs4 interacts with neuronal Irs2 for body weight
regulation. Compared to control mice (Irs2
L/L), the whole body Irs4
 /y mice
grew to a normal size between 6 and 13 weeks of age (Figure 1A).
As shown previously [31], bIrs2
 /  mice were heavier and longer with
signiﬁcantly increased body fat compared with Irs2
L/L mice (Figure 1A
Irs2L/L Irs4-/y
bIrs2-/- Irs4-/y bIrs2-/-
Figure 3: Energy expenditure in bIrs2
 /   Irs4
 /y-mice. (A) Serum leptin levels of 9-month-old male bIrs2
 /   Irs4
 /y-mice, Irs4
 /y-mice, bIrs2
 /  mice and Irs2
L/L mice (n¼8–10, mean7SEM; *,
po0.05 for indicated comparison). (B) Food intake over 24 h in 3-month-old male bIrs2
 /   Irs4
 /y-mice, Irs4
 /y mice, bIrs2
 / -mice or Irs2
L/L-mice fed regular chow diet (mean7SEM; * po0.05
for indicated comparison). Three month-old male mice of the indicated genotype were monitored for 72 h in the CLAMS (n¼10/genotype) to assess (C) oxygen consumption (O2, l/kg/h), and (D) heat
production (kcal/h/kg). Dark phase is presented (mean7SD; * po0.001 for indicated comparison). Heat production was analyzed by generalized linear regression (SPSS, v19), controlling for the effect of body
weight (Bonferroni, po0.001) and (E) RER (respiratory exchange ratio) during the light and dark phases. (F) Representative H&E staining of brown adipose tissue (BAT) of 3-month-old male bIrs2
 /   Irs4
 /y-
mice, Irs4
 /y-mice, bIrs2
 / -mice and Irs2
L/L-mice.
Original article
58 MOLECULAR METABOLISM 3 (2014) 55–63 & 2013 The Authors. Published by Elsevier GmbH. All rights reserved. www.molecularmetabolism.comand D). Through 12 weeks of age, the lack of Irs4 had no effect on
body weight compared against the control mice; however, male
bIrs2
 /   Irs4
 /y mice were 60% heavier than Irs2
L/L and 20% heavier
than bIrs2
 /  animals (Figure 1A and B). Dual X-ray absorptometry
(DEXA) conﬁrmed that the obesity phenotype of bIrs2
 /   Irs4
 /y mice
was due to signiﬁcantly increased adipose mass compared to obese
bIrs2
 /  mice (Figure 1D). Hematoxylin and eosin staining of 6-month-
old mice conﬁrmed that the adipocytes of bIrs2
 /   Irs4
 /y mice were
20% larger (po0.05) than bIrs2
 /  mice (Figure 2A and B). Moreover,
9 month old bIrs2
 /   Irs4
 /y-mice displayed hepatic steatosis similar
to that of ob/ob mice; however, steatosis was never observed in Irs4
 /y,
bIrs2
 /  or control mice (Figure 2C).
Consistent with the graded adiposity of the bIrs2
 /  and bIrs2
 /   Irs4
 /y
-mice, leptin concentrations were elevated in adult bIrs2
 / -mice and
signiﬁcantly greater in the bIrs2
 /   Irs4
-/y mice; however, the leptin
concentration was normal in the Irs4
-/y-mice (Figure 3A). Food intake by
chow-fed controls- and Irs4
 /y-mice was indistinguishable, whereas
bIrs2
 / -mice consumed more food (Figure 3B). The bIrs2
 /   Irs4
 /y
-mice consumed approximately 10% more food than the bIrs2
 / -mice
during the 24-h test interval (Figure 3B). Thus, the lack of Irs4 augmented
hyperphagia only when Irs2 was also absent from the CNS.
Food intake and energy expenditure must be coordinately regulated to
maintain energy balance and stable body weight. Irs2 was previously
shown to alter energy homeostasis as young bIrs2
 /  mice were less
active and consumed less oxygen than age-matched control mice [31].
At 3 months of age, individually housed animals were monitored for
72 h in the Comprehensive Lab Animal Monitoring System (CLAMS).
During the dark cycle, O2 consumption and heat generation were
reduced similarly in bIrs2
 /  and bIrs2
 /   Irs4
 /y-mice compared to
the normal parameters of Irs4
 /y and control mice (Figure 3C and D).
Respiratory exchange ratio (RER) was not different between the groups
(Figure 3E). Nevertheless, compared against bIrs2
 /  mice the
hematoxylin and eosin stained brown adipose tissue (BAT) of adult 6-
month-old bIrs2
 /   Irs4
-/y-mice contained larger lipid-ﬁlled vacuoles
that resembled white adipocytes (Figure 3F). Since Irs2 signaling was
previously shown to play a role in BAT thermoregulation, these ﬁndings
reveal a link between central Irs4 and BAT function that was exposed
when Irs2 was deleted in the CNS [29].
3.3. Hypothalamic neuropeptide expression
To test whether the hyperphagia and obesity of bIrs2
 /   Irs4
 /y-mice
were related to changes in hypothalamic neuropeptide expression, we
measured expression of Npy, Agrp, and Pomc mRNA in the ARC by
qPCR [3]. The expression of mRNA encoding orexigenic neuropeptides
(Npy and Agrp) was increased in bIrs2
 /  and bIrs2
 /   Irs4
 /y-mice,
consistent with the observed hyperphagia of these animals (Figure 4A
and B). By comparison, there were no signiﬁcant changes in the
expression of Pomc mRNA among the various genotypes (Figure 4C).
Overall, the ratio between orexigenic (Agrp) and anorexigenic (Pomc)
mRNAs was similarly increased in bIrs2
-/- and bIrs2
-/- Irs4
 /y mice
compared to Irs4
 /y and control mice (Figure 4D). Thus the mRNA
expression of these hypothalamic neuropeptides was regulated by brain
Irs2, but not inﬂuenced by Irs4.
3.4. Glucose homeostasis in bIrs2
 /   Irs4
 /y-mice
Next, we investigated whether Irs4 synergizes with neuronal Irs2 to
control systemic glucose homeostasis. Fasting glucose concentrations
were normal in 3 month-old Irs4
 /y mice, but slightly increased in
bIrs2
 /  mice and more dramatically increased in bIrs2
 /   Irs4
 /y-
mice (Figure 5A). Similarly, ad libitum-fed blood glucose values trended
upward in the Irs4
 /y and bIrs2
 /  mice, but only reached signiﬁcance
in the bIrs2
 /   Irs4
 /y-mice (Figure 5B). Whereas glucose tolerance
was normal in Irs4
 /y-mice and only slightly impaired in bIrs2
 / 
-mice, bIrs2
 /   Irs4
 /y mice displayed dramatic glucose intolerance
(Figure 5C). Furthermore, the bIrs2
 /   Irs4
 /y-mice were resistant to
the hypoglycemic effects of exogenous insulin, whereas the responses
of bIrs2
 /  and Irs4
 /y mice were not signiﬁcantly different from
controls (Figure 5D). The HOMA2-IR conﬁrmed that insulin resistance
persists in 9 month old bIrs2
 /   Irs4
-/y and bIrs2
 / -mice, whereas
Irs4
 /y mice displayed normal insulin sensitivity (Figure 5E). Consistent
with these results, Irs4
 /y-mice displayed normal insulin concentrations,
whereas the bIrs2
 / -mice displayed slightly elevated circulating
insulin at 9 months of age, whereas insulin concentrations in bIrs2
 /   
Irs4
 /y-mice were elevated approximately 5-fold (Figure 5F). The
bIrs2
 /  mice at 3.5 months displayed 3-fold greater β-cell mass,
which was consistent with the demand for compensatory insulin
secretion (Figure 6A). By comparison, the beta cell mass of 3.5 month
old bIrs2
 /  mice and 7.5 month old Irs4
 /y mice was indistinguish-
able from the controls.
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Figure 4: Levels of mRNA (relative to actin) by RT-PCR of Npy (A), Agrp (B) and Pomc
(C) from hypothalamus of 3-month-old chow-fed male mice of the indicated genotypes.
(D) Ratio between Agrp and Pomc mRNAs (from B, C) for the indicated genotypes. Data are
presented as mean7SEM; * po0.05 for indicated comparisons. (n¼4–5).
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expressing neurons
Leptin, a hormone produced by adipocytes, acts upon leptin receptor (LepRb)
expressing neurons to modulate energy homeostasis [4]. Our recent
observations show that deletion of Irs2 in LepRb neurons (Lepr
ΔIrs2-mice)
increases body weight through the combined effects of hyperphagia and
reduced energy consumption [29]. Since others have suggested that Irs4
mediates PI 3-kinase signaling in response to leptin stimulation [7],i ti s
possible that the synergy between Irs4 and Irs2 occurs in LepRb neurons and
that the deletion of Irs4 would increase the obesity observed in Lepr
ΔIrs2
-mice. However, at 3 months of age the increased body weight of the
Lepr
ΔIrs2-mice was not further increased in the Lepr
ΔIrs2 Irs4
 /y mice
(Figure 7A). Furthermore, while ad libitum-fed blood glucose levels were
signiﬁcantly elevated in the bIrs2
 /   Irs4
 /y mice relative to all other
groups (See Figure 5B, above), blood glucose levels remained unchanged
among Lepr
ΔIrs2, Lepr
ΔIrs2 Irs4
 /y and controls (Figure 7B). Thus, the
synergy between brain Irs2 and Irs4 for body weight control occurs in
neurons that are distinct from LepRb cells.
4. DISCUSSION
Compared to Irs1 and Irs2, for which genetic ablation yields substantial
phenotypes, the physiologic role of Irs4 has been difﬁcult to establish
because the deletion of Irs4 alone produces minimal physiologic
perturbation [33]. Since Irs1 and Irs2 are widely expressed, while
the expression of Irs4 is more narrowly distributed (largely in the
hypothalamus, where Irs2 plays a crucial role in metabolic homeostasis),
we reasoned that Irs2 and Irs4 might play synergistic and somewhat
redundant roles. Indeed, insulin continues to stimulate the
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Figure 5: Glucose homeostasis in bIrs2
 /   Irs4
 /y mice. (A) Fasted and (B) fed blood glucose for 3 month-old male mice. (C) Glucose tolerance test of 3 month-old male mice (n¼
10/genotype). (D) Insulin tolerance test of 4 month-old male mice (n¼9–10/genotype). (E) HOMO2-IR index of insulin resistance (IR) and (F) fasting serum insulin levels (n¼10/genotype) for
9 month-old male mice of the indicated genotypes. Data are expressed as mean7SEM. * po0.05 for indicated comparisons.
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pathway, in hypothalamic extracts from bIrs2
 /  animals [31],
suggesting the persistent and compensatory action of a second IRS-
protein in the hypothalamus.
We thus examined the possibility of functional cooperation between Irs2
and Irs4 in the brain by combining whole body Irs4 deletion (which is
functionally brain-restricted) with brain-speciﬁc Irs2 deletion thereby
focusing on the tissue relevance for any synergistic action and avoiding
the potentially confounding phenotypes associated with deletion of Irs2
in other tissues (such as the islet). Indeed, this analysis revealed
important functional synergy between brain Irs2 and Irs4 in the
regulation of energy balance and glucose homeostasis: To an extent
Figure 7: Lepr
Irs2-mice and Lepr
Irs2 Irs4
 /y-mice display similar body weight and normal blood glucose levels. (A) Average body weights of 3 month-old male bIrs2
 /   Irs4
 /y-mice, Irs4
 /y mice,
bIrs2
 /  mice, Irs2
L/L mice and Lepr
Irs2-mice and Lepr
Irs2 Irs4
 /y-mice. (B) Fed blood glucose levels of 3 month-old male Irs2
L/L mice, Lepr
Irs2-mice and Lepr
Irs2 Irs4
 /y-mice. Mean7SD; n¼6–
8/genotype, *po0.001 for indicated comparisons.
Pancreas Sections
Irs2L/L
(3.5m)
bIrs2-/-
(3.5m)
bIrs2-/-
Irs4-/y
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Irs4-/y
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Irs4-/y Irs2L/L
Figure 6: (A) Representative H&E staining of pancreatic sections of bIrs2
 /   Irs4
 /y mice, Irs4
 /y mice, bIrs2
 /  mice and Irs2
L/L mice at indicated ages. (B) Quantiﬁcation of total pancreatic area
occupied by cells in bIrs2
 /   Irs4
 /y mice, Irs4
 /y mice, bIrs2
 /  mice and Irs2
L/L mice. Data are presented as mean7SEM; * po0.05. (n¼4–5) compared to other genotypes.
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Irs4 in combination promoted obesity and glucose intolerance. The
severe metabolic phenotype in the bIrs2
-/- Irs4
-/y mice thus reveals an
important physiological role for Irs4 that is obscured by the continued
presence of Irs2 in the Irs4
 /y-mice [33], much as the presence of Irs4
mitigates partially the phenotype produced by CNS-speciﬁc Irs2 deletion
in bIrs2
 /  animals. The concerted action of Irs2 and Irs4 contributes
not only to overall adiposity and glucose intolerance, but plays an
especially crucial role in the control of insulin action and hepatic lipid
accumulation, as islet size, HOMA2-IR and hepatic steatosis are
dramatically elevated in bIrs2
 /   Irs4
 /y mice, but do not differ from
controls in the single mutant (bIrs2
 /  and Irs4
 /y) mice.
Our current results, together with previous data, reveal separable
functions for Irs2 and Irs4 expression in distinct neural subsets. The
brain-wide ablation of Irs2 sufﬁces to increase Agrp and Npy expression
relative to Pomc, and promotes obesity and glucose intolerance. LepRb-
restricted disruption of Irs2 expression similarly results in increased
Agrp and Npy (and decreased Pomc) expression [29]. The Lepr
ΔIrs2-
mice also display increased adiposity and decreased glucose tolerance
relative to controls, although the magnitude of their metabolic phenotype
is more modest than that observed in bIrs2
 /  animals[29]. These
ﬁndings suggest that while Irs2 signaling in LepRb cells modulates Agrp,
Npy and Pomc expression and contributes to the control of glucose and
energy homeostasis, Irs2 acts in other (non-LepRb) neurons to mediate
additional aspects of metabolic control.
While Irs4 cooperates with Irs2 in the CNS to modulate energy balance
and glucose homeostasis, Irs4 does not contribute to the control of Agrp,
Npy,o rPomc expression; nor does the absence of Irs4 exacerbate the
phenotype of Lepr
ΔIrs2-mice as it does the metabolic dysfunction of
bIrs2
 /  animals. Thus, our data are consistent with the idea that Irs4
synergizes with Irs2 in non-LepRb neurons to control energy balance
and metabolism independently of LepRb neurons and the leptin-
modulated ARC Pomc and AgRP/Npy neurons. In the future, it will be
important to identify the relevant Irs2/Irs4-expressing non-LepRb cells to
reveal their neurophysiologic function and independent roles in the
control of metabolic homeostasis. Given the distribution of Irs4 and
LepRb, it is tempting to speculate that the crucial Irs4-expressing
neurons could lie in the paraventricular hypothalamic nucleus (PVH),
which is crucial for energy balance and metabolism, but which contains
little LepRb.
Importantly, while Irs4 may not synergize with Irs2 in LepRb neurons, it
remains possible (especially given the distribution of Irs4 expression in
the hypothalamus) that LepRb neurons contain Irs4. The lack of
metabolic phenotype for Irs4
 /y mice and lack of synergy between
Irs2 and Irs4 in LepRb neurons suggests that if Irs4 plays a role in LepRb
neurons, however, the function of Irs4 in LepRb cells must be redundant
with a protein other than Irs2, such as Irs1. Thus, it may be useful to
explore potentially redundant roles for Irs1 and Irs4 in the future,
including in LepRb neurons.
Previous studies suggest that Irs4 might play a role in cellular leptin
action [7]. Serum leptin concentrations are normal in Irs4
 /y-mice,
however. Furthermore, while leptin is elevated in bIrs2
 /   Irs4
 /y
relative to bIrs2
 /  mice (and whole-body bIrs2
þ/ . Irs4
 /y mice
compared to controls [7]), the body weight of obese mice with double
deletion of Irs4 and Irs2 in LepRb neurons (Lepr
ΔIrs2/Irs4 /y) was
indistinguishable from the mice lacking only Irs2 in LepRb neurons
(Lepr
ΔIrs2). These results suggest that Irs4 effect on weight gain in the
brain does not involve LepRb signaling. Indeed, despite the important
role of Irs2 in LepRb neurons, and the hyperleptinemia of animals null
for Irs2 in LepRb cells, leptin signals normally to decrease body weight
in young Lepr
ΔIrs2-mice [29]. Thus, neither Irs2 nor Irs4 in LepRb
neurons is required for leptin action, but rather presumably mediate
crucial insulin signals in LepRb cells (Irs2) and non-LepRb cells (Irs2 and
Irs4). Insulin action in the hypothalamus mediates important effects
upon body weight and nutrient homeostasis through signaling cascades
which regulate food intake, glucose and lipid metabolism, and energy
expenditure [3]. Both Irs2 and Irs4 are expected to promote the PI3K-
Akt ┤FoxO1 cascade in hypothalamic neurons, as elsewhere in the
body; this pathway is known to play a crucial role in the hypothalamic
control of metabolic regulation [39].
Overall, our results suggest that Irs2 and Irs4 synergize in non-LepRb
neurons to mediate central insulin action, thereby controlling a variety of
metabolically important phenotypes. While it contributes to the control of
energy balance, Irs4 plays an especially crucial role in the control of
whole-body insulin sensitivity and glucose homeostasis.
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